Daejeon
South Korea
5
2024-01-04
4
2025-12-09
These are the the leading inventors for applications assigned to GENOFOCUS CO., LTD.:
GENOFOCUS CO., LTD. based in Daejeon, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
USE OF POLYPEPTIDE HAVING SUPEROXIDE DISMUTASE ACTIVITY AND EXTRACELLULAR VESICLES FOR TREATMENT OR PREVENTION OF RESPIRATORY VIRAL INFECTION
#2 | 2022-09-08 ✅ Patent 12,492,228 granted on 2025-12-09CRM197 PROTEIN EXPRESSION METHOD
#3 | 2018-07-19 ✅ Patent 10,472,616 granted on 2019-11-12Genes encoding alpha-1,3-glucanase and methods of using the same
#4 | 2018-06-07 ✅ Patent 10,526,592 granted on 2020-01-07Beta-galactosidase variant having high transglycosylation activity, and use thereof
#5 | 2017-07-13 ✅ Patent 10,036,000 granted on 2018-07-31Beta-galactosidase
Also check out GENOFOCUS CO., LTD.'s (Daejeon, South Korea) applicant profile with 4 patent applications submitted.
135837 ⎘